
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Schizophrenia, Schizoaffective Disorder
View Full LandscapeTarget Indication
Schizophrenia, Schizoaffective Disorder
Clinical Trial
NCT04512066Last updated: 1/6/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma
Colorectal Cancer
Anemia
Metastatic Breast Cancer
Rheumatoid Arthritis